Aravax

Developer of vaccine for peanut allergy

placeMelbourne, Victoria, Australia calendar_todayFounded 2015 groups2 employees language aravax.com.au

Social engagement

Social engagement: 1.7K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Medical Research Commercialisation Fund, Tenmile, Brandon BioCatalyst.

Investor typeCountShare
Venture capital788%
Other / undisclosed113%

Recent activity

1 May 2026
Event
BioCentury Inc. EBD Group 26th
8 Apr 2026
Leadership hire
Board of Directors
11 Mar 2026
Event
BioEurope Spring Informa Connect EBD Group and LSX World Congress Europe
Coming soon